Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer

Summary. Background: The development of malignant tumors, including esophageal cancer (EC), could be associated with impaired expression of oncosuppressive miRNA-200b and еxcision repair cross-complementing group-1 (ERCC1), a protein involved in DNA repair and alternative splicing. Aim: To investiga...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Kirkilevsky, S.I., Krakhmalev, P.S., Malyshok, N.V., Zadvornyi, T.V., Borikun, T.V., Yalovenko, T.M.
Format: Artikel
Sprache:Englisch
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
_version_ 1856543491829530624
author Kirkilevsky, S.I.
Krakhmalev, P.S.
Malyshok, N.V.
Zadvornyi, T.V.
Borikun, T.V.
Yalovenko, T.M.
author_facet Kirkilevsky, S.I.
Krakhmalev, P.S.
Malyshok, N.V.
Zadvornyi, T.V.
Borikun, T.V.
Yalovenko, T.M.
author_sort Kirkilevsky, S.I.
baseUrl_str
collection OJS
datestamp_date 2023-10-11T16:43:26Z
description Summary. Background: The development of malignant tumors, including esophageal cancer (EC), could be associated with impaired expression of oncosuppressive miRNA-200b and еxcision repair cross-complementing group-1 (ERCC1), a protein involved in DNA repair and alternative splicing. Aim: To investigate the features of expression of miRNA-200b and ERCC1 in tumor cells of patients with EC and to determine the possibility of their use for prediction of EC aggressiveness. Materials and Methods: 52 patients with EC of stages II–IV were enrolled. Expression of ERCC1 in tumor cells was assessed by immunohistochemical method, expression of miRNA-200b was evaluated by the real time reverse transcription-polymerase chain reaction. Results: The expression of miRNA-200b and ERCC1 in tumor cells of EC patients is associated with their life expectancy. The characteristic features of neoplasms in patients who died within 12 months are low expression of miRNA-200b (2.87 ± 1.65 a.u.) (ρ = –0.42; p < 0.05) and high expression of ERCC1 (191.0 ± 18.6 H-Score points) (ρ = –0.48; p < 0.05). The inverse correlations between the level of miRNA-200b expression and the tumor size were found both in the group of patients with survival < 12 months (ρ = –0.42; p < 0.05) and in the group of patients with survival > 12 months after surgery (ρ = –0.53; p < 0.05). Conclusions: The obtained data indicate the feasibility of using the expression of miRNA-200b and ERCC1 in EC cells to predict the aggressiveness of esophageal cancer.
first_indexed 2025-07-17T12:16:02Z
format Article
id oai:ojs2.ex.aqua-time.com.ua:article-166
institution Experimental Oncology
language English
last_indexed 2025-07-17T12:16:02Z
publishDate 2023
publisher PH Akademperiodyka
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-1662023-10-11T16:43:26Z Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer Kirkilevsky, S.I. Krakhmalev, P.S. Malyshok, N.V. Zadvornyi, T.V. Borikun, T.V. Yalovenko, T.M. aggressiveness of cancer, ERCC1, esophageal cancer, miRNA 200b aggressiveness of cancer, ERCC1, esophageal cancer, miRNA 200b Summary. Background: The development of malignant tumors, including esophageal cancer (EC), could be associated with impaired expression of oncosuppressive miRNA-200b and еxcision repair cross-complementing group-1 (ERCC1), a protein involved in DNA repair and alternative splicing. Aim: To investigate the features of expression of miRNA-200b and ERCC1 in tumor cells of patients with EC and to determine the possibility of their use for prediction of EC aggressiveness. Materials and Methods: 52 patients with EC of stages II–IV were enrolled. Expression of ERCC1 in tumor cells was assessed by immunohistochemical method, expression of miRNA-200b was evaluated by the real time reverse transcription-polymerase chain reaction. Results: The expression of miRNA-200b and ERCC1 in tumor cells of EC patients is associated with their life expectancy. The characteristic features of neoplasms in patients who died within 12 months are low expression of miRNA-200b (2.87 ± 1.65 a.u.) (ρ = –0.42; p < 0.05) and high expression of ERCC1 (191.0 ± 18.6 H-Score points) (ρ = –0.48; p < 0.05). The inverse correlations between the level of miRNA-200b expression and the tumor size were found both in the group of patients with survival < 12 months (ρ = –0.42; p < 0.05) and in the group of patients with survival > 12 months after surgery (ρ = –0.53; p < 0.05). Conclusions: The obtained data indicate the feasibility of using the expression of miRNA-200b and ERCC1 in EC cells to predict the aggressiveness of esophageal cancer. Summary. Background: The development of malignant tumors, including esophageal cancer (EC), could be associated with impaired expression of oncosuppressive miRNA-200b and еxcision repair cross-complementing group-1 (ERCC1), a protein involved in DNA repair and alternative splicing. Aim: To investigate the features of expression of miRNA-200b and ERCC1 in tumor cells of patients with EC and to determine the possibility of their use for prediction of EC aggressiveness. Materials and Methods: 52 patients with EC of stages II–IV were enrolled. Expression of ERCC1 in tumor cells was assessed by immunohistochemical method, expression of miRNA-200b was evaluated by the real time reverse transcription-polymerase chain reaction. Results: The expression of miRNA-200b and ERCC1 in tumor cells of EC patients is associated with their life expectancy. The characteristic features of neoplasms in patients who died within 12 months are low expression of miRNA-200b (2.87 ± 1.65 a.u.) (ρ = –0.42; p < 0.05) and high expression of ERCC1 (191.0 ± 18.6 H-Score points) (ρ = –0.48; p < 0.05). The inverse correlations between the level of miRNA-200b expression and the tumor size were found both in the group of patients with survival < 12 months (ρ = –0.42; p < 0.05) and in the group of patients with survival > 12 months after surgery (ρ = –0.53; p < 0.05). Conclusions: The obtained data indicate the feasibility of using the expression of miRNA-200b and ERCC1 in EC cells to predict the aggressiveness of esophageal cancer. PH Akademperiodyka 2023-05-31 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-3 10.32471/exp-oncology.2312-8852.vol-42-no-3.14822 Experimental Oncology; Vol. 42 No. 3 (2020): Experimental Oncology; 167-171 Експериментальна онкологія; Том 42 № 3 (2020): Експериментальна онкологія; 167-171 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-3 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-3/2020-3-3 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle aggressiveness of cancer
ERCC1
esophageal cancer
miRNA 200b
Kirkilevsky, S.I.
Krakhmalev, P.S.
Malyshok, N.V.
Zadvornyi, T.V.
Borikun, T.V.
Yalovenko, T.M.
Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title_alt Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title_full Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title_fullStr Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title_full_unstemmed Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title_short Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
title_sort prognostic significance of microrna-200b and ercc1 expression in tumor cells of patients with esophageal cancer
topic aggressiveness of cancer
ERCC1
esophageal cancer
miRNA 200b
topic_facet aggressiveness of cancer
ERCC1
esophageal cancer
miRNA 200b
aggressiveness of cancer
ERCC1
esophageal cancer
miRNA 200b
url https://exp-oncology.com.ua/index.php/Exp/article/view/2020-3-3
work_keys_str_mv AT kirkilevskysi prognosticsignificanceofmicrorna200bandercc1expressionintumorcellsofpatientswithesophagealcancer
AT krakhmalevps prognosticsignificanceofmicrorna200bandercc1expressionintumorcellsofpatientswithesophagealcancer
AT malyshoknv prognosticsignificanceofmicrorna200bandercc1expressionintumorcellsofpatientswithesophagealcancer
AT zadvornyitv prognosticsignificanceofmicrorna200bandercc1expressionintumorcellsofpatientswithesophagealcancer
AT borikuntv prognosticsignificanceofmicrorna200bandercc1expressionintumorcellsofpatientswithesophagealcancer
AT yalovenkotm prognosticsignificanceofmicrorna200bandercc1expressionintumorcellsofpatientswithesophagealcancer